1 | 1 | | |
---|
2 | 2 | | |
---|
3 | 3 | | EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW. |
---|
4 | 4 | | [Brackets] indicate matter deleted from existing law. |
---|
5 | 5 | | *hb1176* |
---|
6 | 6 | | |
---|
7 | 7 | | HOUSE BILL 1176 |
---|
8 | 8 | | J1 2lr2494 |
---|
9 | 9 | | CF SB 859 |
---|
10 | 10 | | By: Delegate McComas |
---|
11 | 11 | | Introduced and read first time: February 11, 2022 |
---|
12 | 12 | | Assigned to: Health and Government Operations |
---|
13 | 13 | | |
---|
14 | 14 | | A BILL ENTITLED |
---|
15 | 15 | | |
---|
16 | 16 | | AN ACT concerning 1 |
---|
17 | 17 | | |
---|
18 | 18 | | Public Health – Sickle Cell Disease Registry – Establishment 2 |
---|
19 | 19 | | |
---|
20 | 20 | | FOR the purpose of requiring the Maryland Department of Health to establish and 3 |
---|
21 | 21 | | maintain a registry of individuals diagnosed with sickle cell disease for a certain 4 |
---|
22 | 22 | | purpose; requiring the Department to periodically publish information identifying 5 |
---|
23 | 23 | | areas with statistically high populations of individuals with sickle cell disease; and 6 |
---|
24 | 24 | | generally relating to a sickle cell disease registry. 7 |
---|
25 | 25 | | |
---|
26 | 26 | | BY adding to 8 |
---|
27 | 27 | | Article – Health – General 9 |
---|
28 | 28 | | Section 18–508 10 |
---|
29 | 29 | | Annotated Code of Maryland 11 |
---|
30 | 30 | | (2019 Replacement Volume and 2021 Supplement) 12 |
---|
31 | 31 | | |
---|
32 | 32 | | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 13 |
---|
33 | 33 | | That the Laws of Maryland read as follows: 14 |
---|
34 | 34 | | |
---|
35 | 35 | | Article – Health – General 15 |
---|
36 | 36 | | |
---|
37 | 37 | | 18–508. 16 |
---|
38 | 38 | | |
---|
39 | 39 | | (A) THE DEPARTMENT SHALL ESTA BLISH AND MAINTAIN A REGISTRY OF 17 |
---|
40 | 40 | | INDIVIDUALS DIAGNOSE D WITH SICKLE CELL D ISEASE FOR USE AS A SINGLE 18 |
---|
41 | 41 | | REPOSITORY OF ACCURA TE, COMPLETE RECORDS TO AID IN PROMOTING THE SITING 19 |
---|
42 | 42 | | OF THE FOLLOWING HEALTH CARE PROVIDERS IN AR EAS WITH STATISTICALL Y HIGH 20 |
---|
43 | 43 | | POPULATIONS OF INDIV IDUALS WITH SICKLE C ELL DISEASE: 21 |
---|
44 | 44 | | |
---|
45 | 45 | | (1) HEALTH CARE FACILITIE S THAT PROVIDE INFUSION THE RAPY; 22 |
---|
46 | 46 | | AND 23 |
---|
47 | 47 | | 2 HOUSE BILL 1176 |
---|
48 | 48 | | |
---|
49 | 49 | | |
---|
50 | 50 | | (2) HEMATOLOGIST OFFICES. 1 |
---|
51 | 51 | | |
---|
52 | 52 | | (B) THE SICKLE CELL DISEA SE REGISTRY ESTABLIS HED UNDER 2 |
---|
53 | 53 | | SUBSECTION (A) OF THIS SECTION SHALL INCLUD E: 3 |
---|
54 | 54 | | |
---|
55 | 55 | | (1) A RECORD OF INDIVIDUAL S IN THE STATE WHO HAVE BEEN 4 |
---|
56 | 56 | | DIAGNOSED WITH SICKL E CELL DISEASE; AND 5 |
---|
57 | 57 | | |
---|
58 | 58 | | (2) ANY OTHER INFORMATION REGARDING INDIVIDUAL S WHO HAVE 6 |
---|
59 | 59 | | BEEN DIAGNOSED WITH SICKLE CELL DISEASE THAT THE DEPARTMENT CONSIDERS 7 |
---|
60 | 60 | | NECESSARY AND APPROPRIATE FOR INCLUSION ON THE REGISTRY. 8 |
---|
61 | 61 | | |
---|
62 | 62 | | (C) (1) THE DEPARTMENT SHALL ESTA BLISH A PROCESS AND 9 |
---|
63 | 63 | | GUIDELINES FOR : 10 |
---|
64 | 64 | | |
---|
65 | 65 | | (I) OBTAINING INFORMATION REGARDING AN INDIVID UAL 11 |
---|
66 | 66 | | DIAGNOSED WITH SICKL E CELL DISEASE FROM HEALTH CARE FACILITI ES FOR USE 12 |
---|
67 | 67 | | IN THE REGISTRY; AND 13 |
---|
68 | 68 | | |
---|
69 | 69 | | (II) ENSURING THAT THE REG ISTRY AND THE PROCESS OF 14 |
---|
70 | 70 | | OBTAINING INFORMATION FOR THE REGISTRY COMPLY WITH THE REQUIREMENT S 15 |
---|
71 | 71 | | OF § 18–504 OF THIS SUBTITLE , § 13–109 OF THIS ARTICLE , THE HEALTH 16 |
---|
72 | 72 | | INSURANCE PORTABILITY AND ACCOUNTABI LITY ACT OF 1996, AND ANY OTHER 17 |
---|
73 | 73 | | APPLICABLE PRIVACY L AW. 18 |
---|
74 | 74 | | |
---|
75 | 75 | | (2) THE DEPARTMENT MAY USE AN Y AVAILABLE SOURCES OF DATA 19 |
---|
76 | 76 | | FOR THE REGISTRY OR AS PART OF THE PROCE SS AND GUIDELINES ES TABLISHED 20 |
---|
77 | 77 | | UNDER PARAGRAPH (1) OF THIS SUBSECTION , INCLUDING: 21 |
---|
78 | 78 | | |
---|
79 | 79 | | (I) DATA FROM T HE DESIGNATED HEALTH INFORMATION 22 |
---|
80 | 80 | | EXCHANGE IN THE STATE; 23 |
---|
81 | 81 | | |
---|
82 | 82 | | (II) CENSUS–TRACT LEVEL DATA ; AND 24 |
---|
83 | 83 | | |
---|
84 | 84 | | (III) INFORMATION COLLECTED FROM VITAL RECORDS . 25 |
---|
85 | 85 | | |
---|
86 | 86 | | (D) A HEALTH CARE PROVIDER WHO PROVIDES HEALTH CARE TO AN 26 |
---|
87 | 87 | | INDIVIDUAL WITH SICKLE CELL DIS EASE SHALL PROVIDE TO THE DEPARTMENT ANY 27 |
---|
88 | 88 | | INFORMATION IN THE F ORM AND MANNER REQUIRED BY THE GUIDELINES 28 |
---|
89 | 89 | | ESTABLISHED UNDER SUBSECTION (C) OF THIS SECTION. 29 |
---|
90 | 90 | | |
---|
91 | 91 | | (E) TO THE EXTENT AUTHORI ZED BY LAW , THE DEPARTMENT SHALL 30 |
---|
92 | 92 | | PERIODICALLY PUBLISH INFORMATION IDENTIFY ING AREAS WITH STATI STICALLY 31 HOUSE BILL 1176 3 |
---|
93 | 93 | | |
---|
94 | 94 | | |
---|
95 | 95 | | HIGH POPULATIONS OF INDIVIDUALS WITH SIC KLE CELL DISEASE , WHICH MAY 1 |
---|
96 | 96 | | INCLUDE INFORMATION PUBLISHED IN A MAP . 2 |
---|
97 | 97 | | |
---|
98 | 98 | | SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect 3 |
---|
99 | 99 | | October 1, 2022. 4 |
---|